Login  
HSRO Home


Search

 Go
Advanced Search


Investigator Resources

Information for Research Participants
Information for Study Teams
Information for Sponsors
Institutional Review Boards
UM Policies & Procedures - HSRO/IRB
1. Preface
2. Background Topics
3. Authorities and Responsibilities
4. Conflict of Interest
5. Institutional Review Boards
6. IRB Meetings
7. General Principles for IRB Reviews
8. Definition of IRB Review Types
9. IRB Review of Initial Studies
10. IRB Review of Continuing Studies
11. Amendments
12. Closing Studies and Final Reports
13. Suspension, Termination and Administrative Closure of IRB Approved Research
14. Unanticipated Problems and Adverse Events
15. Study Violations
16. Compliance Audits
17. Data Safety Monitoring Boards
18. Ancillary Committees
19. External IRB's
20. Policies Specific to Certain Types of Research
21. Informed Consent
22. Participant Recruitment Methods, Advertising Materials and Recruitment-Relevant Payment Arrangements
23. Vulnerable Populations
24. Privacy, Security, Confidentiality and HIPAA
25. Subcontracts/Agreements for UM-Initiated Studies that Engage or Involve non-UM Institutions or Investigators
26. International Research
27. Emergency Use
28. Record Retention
Other Policies
UChart Forms & Guidance
HSRO Forms & Documents
University Fees
Ancillary Committee Information
eProst User Guide
Ethics, Federal Regulations & Guidance
HIPAA
Translations
Western IRB (WIRB)
About the HSRO


Basic Folder Information

11.3 Changing Principal Investigators or Co-Investigators



Approval Date

Review Responsibility:

IRB Policy and Procedure Committee

Original Approval Date:

February 21, 2006

Revised: February 13, 2012; October 5th, 2012

 



11.3 Changing Principal Investigators

Requests to change the Principal Investigator (PI) of an active study must be forwarded within an Amendment Form for review on an expedited basis by the IRB chair or IRB-designee. If the Chair-designee believes that review by the convened IRB is required, the request shall be forwarded to the IRB for its review.  Such request shall include a letter from the current PI indicating the change in responsibility and its rationale and a letter from the new PI accepting responsibility for the research.  If the PI has left the University or is unable to provide an explanatory letter, the amendment/request to change the PI may come from the chair of the academic department or the director of the institutional research center that provides the administrative support and oversight to the study.

If the PI requesting the change within an active study holds an IND or IDE for the study, he/she must decide whether to continue to hold the IND/IDE or to transfer the IND/IDE to the new PI. In the latter case, the current PI (the IND/IDE holder) must inform the FDA in writing that he/she is turning over the IND number and responsibilities to the new PI; and the new PI must inform the FDA in writing of acceptance of the responsibility for the IND number and that all documents relating to the IND have been transferred to him/her.

Co-Investigators provide additional leadership to a study and may bring to the study similar or complementary expertise required for study conduct. Requests to change (or remove) a Co-Investigator may be reviewed and approved  by an IRB Chair or designee through the expedited process. The IRB Chair or designee will ensure that the change or removal of the Co-Investigator does not lead to increased risk to the subjects and is made in accordance with prior IRB determinations related to the study. If the Chair believes that review by the convened IRB is required, the request shall be forwarded to the IRB for its review.

Additionally, any absence by the PI expected to last 30 calendar days or more requires the submission of a notification to the IRB detailing how the study will be conducted during this absence and who will provide oversight of the study conduct during the PI's absence from the institution (i.e. leave, sabbatical, etc.)



Footer Block

University of Miami Office of Research UM School of Medicine CITI Program Jackson Health System
 University of Miami logo University of Miami
Human Subjects Research Office

1500 NW 12th Avenue, Ste. 1002, Miami, FL 33136
Tel. 305-243-3195
Copyright, University of Miami, All Rights Reserved
Requests for information. Send technical feedback.
View Privacy statement